发明名称 |
ASPIRIN-CONTAINING PHARMACEUTICAL AGENT |
摘要 |
<p>Disclosed is a pharmaceutical agent effective for the prevention and/or treatment of a disease associated with the formation of a thrombus or embolus or a disease induced by the formation of a thrombus or embolus. The pharmaceutical agent comprises a combination of aspirin and any one of the following compounds (a) to (d): (a) a compound capable of acting on a calcium handling protein to modulate the intracellular calcium level or the rate of change in intracellular calcium level; (b) a compound capable of inhibiting the over-accumulation of a calcium ion in a cell; (c) a compound capable of inhibiting the over-accumulation of a sodium ion in a cell; and (d) an aminobenzenesulfonic acid derivative represented by the general formula (I), a salt thereof, or a hydrate or solvate of the derivative or the salt. (I) wherein R<SUB>1</SUB> represents a C<SUB>1</SUB>-C<SUB>6</SUB> alkyl group or the like; R<SUB>2</SUB> represents a hydrogen atom or the like; and n represents an integer of 1 to 4.</p> |
申请公布号 |
WO2008032814(A1) |
申请公布日期 |
2008.03.20 |
申请号 |
WO2007JP67910 |
申请日期 |
2007.09.14 |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION;WATANABE, MAYUMI |
发明人 |
WATANABE, MAYUMI |
分类号 |
A61K31/616;A61K31/495;A61K45/00;A61P7/02;A61P9/04;A61P9/08;A61P9/10;A61P41/00;A61P43/00;C07D295/08 |
主分类号 |
A61K31/616 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|